Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Dafo Vehicle
Mandate

Vinge advises on the sale of Dafo Vehicle

December 05, 2024 M&A Automotive, Mobility and Electrification

Vinge has advised Sobro and the other owners in connection with the sale of Dafo Vehicle to the US based United Safety & Survivability Corporation. Dafo Vehicle is a leading supplier of fire detection and suppression systems for vehicles and the acquisition creates a global leader within vehicle safety systems.

Vinge's team primarily consisted of Johan Winnerblad, Manon De Cooman, Eléonore Friberg, Philip Moré and Saga Meyer Viklund (M&A), Johan Cederblad (Environmental), Jolene Reimerson and Jacob Eberil (Commercial Agreements), Ian Jonson (IP), Jessica Öijer, Johanna Engström and Christoffer Widström (Transaction Support).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026